Peripheral blood microbiome signature and Mycobacterium tuberculosis-derived rsRNA as diagnostic biomarkers for tuberculosis in human
Authors:
Open Access
- 19 February 2025
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-14
Abstract
Tuberculosis (TB) is a major global health issue. Early diagnosis of TB is still a challenge. Studies are seeking non-sputum biomarker-based TB test. Emerging evidence indicates potential significance of blood microbiome signatures for diseases. However, blood microbiome RNA profiles are unknown in TB. We aimed to characterize the blood microbiome of TB patients and identify Mycobacterium tuberculosis (Mtb) genome-derived small RNA molecules to serve as diagnostic biomarkers for TB. RNA sequencing data of the blood from TB patients and healthy controls were retrieved from the NCBI-SRA database for analyzing the blood microbiome and identifying rRNA-derived small RNA (rsRNA) of Mtb. Small RNA-seq was performed on plasma exosomes from TB patients and healthy controls. The levels of the candidate Mtb rsRNAs were determined by real-time quantitative reverse transcription PCR (RT-qPCR) on plasma from a separate cohort of 73 TB patients and 62 healthy controls. The blood microbiome of TB patients consisted of RNA signals from bacteria, fungi, archaea, and viruses, with bacteria accounting for more than 97% of the total. Reduced blood microbial diversity and abundance of 6 Mycobacterium-associated bacterial genera, including Mycobacterium, Priestia, Nocardioides, Agrobacterium, Bradyrhizobium, and Escherichia, were significantly altered in the blood of TB patients. A diagnostic model for TB based on the 6 genera achieved an area under the curve (AUC) of 0.8945. rsRNAs mapped to the Mtb genome were identified from blood and plasma exosomes of TB patients. RT-qPCR results showed that 2 Mtb-derived rsRNAs, 16 S-L1 and 16 S-L2, could be used as diagnostic biomarkers to differentiate TB patients from healthy controls, with a high co-diagnostic efficacy (AUC = 0.7197). A panel of blood microbiome signatures and Mtb-derived rsRNAs can serve as blood biomarkers for TB diagnosis.Keywords
Funding Information
- National Major Science and Technology Projects of China (2017ZX10201301–003–005)
- Heilongjiang Provincial Natural Science Foundation (LH2024H014)
This publication has 83 references indexed in Scilit:
- The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goalsHealth Science Reports, 2024
- Animal migration optimization algorithm: novel optimizer, analysis, and applications2024
- Boosted Aquila Arithmetic Optimization Algorithm for multi-level thresholding image segmentationEvolving Systems, 2024
- Improved Manta Ray Foraging Optimizer-based SVM for Feature Selection Problems: A Medical Case StudyJournal of Bionic Engineering, 2023
- Priestia flexa KS1: A new bacterial strain isolated from human faeces implicated in mucin degradationInternational Microbiology, 2022
- Exploring blood microbial communities and their influence on human cardiovascular diseaseJournal of Clinical Laboratory Analysis, 2022
- Microbiota‐derived extracellular vesicles in interkingdom communication in the gutJournal of Extracellular Vesicles, 2021
- Distinct lung microbial community states in patients with pulmonary tuberculosisScience China Life Sciences, 2020
- Association between blood microbiome and type 2 diabetes mellitus: A nested case‐control studyJournal of Clinical Laboratory Analysis, 2019
- Rhizobium radiobacter bacteremia in a neonateInfection, 2011